Connection

Badih Elmunzer to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Badih Elmunzer has written about Cost-Benefit Analysis.
Badih Elmunzer
Connection Strength
0.120
Cost-Benefit Analysis
  1. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol. 2013 Mar; 108(3):410-5.
    View in: PubMed
    Score: 0.088
  2. Cost-effectiveness analysis comparing lumen-apposing metal stents with plastic stents in the management of pancreatic walled-off necrosis. Gastrointest Endosc. 2018 08; 88(2):267-276.e1.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.